Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.3300
0.00 (0.00%)
At close: Aug 7, 2026

Cleo Diagnostics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
9.436.469.370.24-
Cash & Short-Term Investments
9.436.469.370.24-
Cash Growth
45.91%-31.07%3809.00%--
Other Receivables
0.10.070.060.03-
Receivables
0.10.070.060.03-
Prepaid Expenses
0.080.010.010.31-
Total Current Assets
9.66.559.440.58-
Property, Plant & Equipment
0.030.030.030.04-
Other Intangible Assets
0.330.360.410.46-
Total Assets
9.966.949.881.08-

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
1.010.870.270.31-
Accrued Expenses
0.130.10.050-
Short-Term Debt
---1.6-
Other Current Liabilities
-0.130.170.1-
Total Current Liabilities
1.141.10.492.02-
Total Liabilities
1.141.10.492.02-

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
18.0913.7113.710.05-
Retained Earnings
-11.52-9.53-5.53-1.77-
Comprehensive Income & Other
2.251.661.220.78-
Shareholders' Equity
8.835.839.39-0.94-
Total Liabilities & Equity
9.966.949.881.08-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
---1.6-
Net Cash (Debt)
9.436.469.37-1.36-
Net Cash Growth
45.91%-31.07%---
Net Cash Per Share
0.070.050.08-0.05-
Filing Date Shares Outstanding
136.86128.5128.544.09-
Total Common Shares Outstanding
136.86128.5128.544.09-
Working Capital
8.465.448.95-1.44-
Book Value Per Share
0.060.050.07-0.02-
Tangible Book Value
8.495.488.98-1.4-
Tangible Book Value Per Share
0.060.040.07-0.03-
Machinery
-0.050.040.04-